Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MaxWin International HoldingsHKSE:08513 +3.13%53 EBITDA Margin % is 2.10% as of Dec. 2025, which is 209% above its 10-year median of 0.68. GuruFocus rates HKSE:08513 with a GF Score™ of 53/100 and a GF Value™ of HK$1.98 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, MaxWin International Holdings ranks worse than 57.18% on this metric.
MaxWin International Holdings (HKSE:08513) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
MaxWin International Holdings EBITDA Margin % Related Terms
MaxWin International Holdings EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MaxWin International Holdings EBITDA Margin % Chart
HKSE:08513 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, MaxWin International Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MaxWin International Holdings EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MaxWin International Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where MaxWin International Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MaxWin International Holdings (HKSE:08513) has a EBITDA Margin % of 2.10% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MaxWin International Holdings and its competitors. This is 209% above median its historical median of 0.68. According to the industry distribution chart, MaxWin International Holdings ranks #466 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 57.2%.
Is MaxWin International Holdings' EBITDA Margin % too high?
MaxWin International Holdings' current EBITDA Margin % of 2.10% is 209% above median its 10-year median of 0.68. The Medical Devices & Instruments industry median EBITDA Margin % is 7.52. MaxWin International Holdings' value of 2.10% is 72.1% below this industry median. Based on the distribution chart, MaxWin International Holdings ranks #466 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, MaxWin International Holdings has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MaxWin International Holdings' EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, MaxWin International Holdings ranks #466 out of 815 companies for EBITDA Margin %. This places MaxWin International Holdings in the lower half of its industry. The industry median EBITDA Margin % is 7.52. MaxWin International Holdings' value of 2.10% is 72.1% below this benchmark. While the company's 10-year median is 0.68 vs. the industry median of 7.52, MaxWin International Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.52, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MaxWin International Holdings's current EBITDA Margin % of 2.10% is 72.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MaxWin International Holdings and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MaxWin International Holdings's current EBITDA Margin % is 2.10%, which is 209% above median its own 10-year median of 0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MaxWin International Holdings stock overvalued right now?
Based on GuruFocus' analysis, MaxWin International Holdings (HKSE:08513) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.98, compared to a current price of HK$0.33 — trading 83.3% below its estimated fair value. The current EBITDA Margin % is 2.10%, which is 209% above median its 10-year median of 0.68 and 72.1% below the Medical Devices & Instruments industry median of 7.52. MaxWin International Holdings' overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For MaxWin International Holdings (HKSE:08513), the current EBITDA Margin % is 2.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MaxWin International Holdings (HKSE:08513) Overvalued in 2026?
Based on GuruFocus' analysis, MaxWin International Holdings stock appears to be undervalued.
The current stock price of HK$0.33 is trading 83.3% below its estimated GF Value™ of HK$1.98.
GuruFocus considers MaxWin International Holdings to be Possible Value Trap.
Key valuation signals for HKSE:08513:
EBITDA Margin %: 2.10% (209% above median its 10-year median of 0.68)
GF Value™: HK$1.98 vs. price of HK$0.33 (83.3% below fair value)
Industry Position: 72.1% below the Medical Devices & Instruments median (#466 of 815)
No single metric tells the full story. See the HKSE:08513 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MaxWin International Holdings Business Description
MaxWin International Holdings Ltd is engaged in the manufacturing and sale of injection molded plastic parts for disposable medical devices and the provision of tooling services in Singapore. The group also operates in data solutions and services involving IT-related products and maintenance services, as well as hospitality operations. It has four reportable segments: Component Parts, Sub-assembly Parts, Data Solutions and Services, and Hospitality. It generates the majority of its revenue from the Component Parts segment. Geographically, it generates the majority of its revenue from Mainland China.
53GF Score
Get the complete analysis for HKSE:08513
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08513 has been successfully added to your 
